相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Potential of miRNAs in urinary extracellular vesicles for management of active surveillance in prostate cancer patients
Manuel Ramirez-Garrastacho et al.
BRITISH JOURNAL OF CANCER (2022)
Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Multiple cancer type classification by small RNA expression profiles with plasma samples from multiple facilities
Kuno Suzuki et al.
CANCER SCIENCE (2022)
Circulating microRNA profiling for prediction of oncological outcomes in prostate cancer patients following radical prostatectomy
Hajime Takamori et al.
PROSTATE (2022)
Treatments for Metastatic Hormone-sensitive Prostate Cancer: Systematic Review, Network Meta-analysis, and Benefit-harm assessment
Dominik Menges et al.
EUROPEAN UROLOGY ONCOLOGY (2022)
Diagnostic Value of microRNA-375 as Future Biomarker for Prostate Cancer Detection: A Meta-Analysis
Diana Nitusca et al.
MEDICINA-LITHUANIA (2022)
Post-transcriptional Gene Regulation by MicroRNA-194 Promotes Neuroendocrine Transdifferentiation in Prostate Cancer
Rayzel C. Fernandes et al.
CELL REPORTS (2021)
Castration-Induced Downregulation of SPARC in Stromal Cells Drives Neuroendocrine Differentiation of Prostate Cancer
Claudia Enriquez et al.
CANCER RESEARCH (2021)
Extracellular vesicles in the development of organ-specific metastasis
Fumihiko Urabe et al.
JOURNAL OF EXTRACELLULAR VESICLES (2021)
Androgens alter the heterogeneity of small extracellular vesicles and the small RNA cargo in prostate cancer
Elena S. Martens-Uzunova et al.
JOURNAL OF EXTRACELLULAR VESICLES (2021)
The regulation of HAS3 by miR-10b and miR-29a in neuroendocrine transdifferentiated LNCaP prostate cancer cells
Elena D. Czyrnik et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
MiR-509-3 augments the synthetic lethality of PARPi by regulating HR repair in PDX model of HGSOC
Chenggong Sun et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours
David S. Hong et al.
BRITISH JOURNAL OF CANCER (2020)
Tumor-associated macrophages promote prostate cancer progression via exosome-mediated miR-95 transfer
Han Guan et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Role of miRNAs in prostate cancer: Do we really know everything?
Giovanni Cochetti et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2020)
Combined TP53 and RB1 Loss Promotes Prostate Cancer Resistance to a Spectrum of Therapeutics and Confers Vulnerability to Replication Stress
Michael D. Nyquist et al.
CELL REPORTS (2020)
The diagnostic value of miRNA-141 in prostate cancer A systematic review and PRISMA-compliant meta-analysis
Yun Ye et al.
MEDICINE (2020)
miR-26a regulates extracellular vesicle secretion from prostate cancer cells via targeting SHC4, PFDN4, and CHORDC1
Fumihiko Urabe et al.
SCIENCE ADVANCES (2020)
Olaparib for Metastatic Castration-Resistant Prostate Cancer
J. de Bono et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The miR-1908/SRM regulatory axis contributes to extracellular vesicle secretion in prostate cancer
Fumihiko Urabe et al.
CANCER SCIENCE (2020)
LIN28B promotes the development of neuroendocrine prostate cancer
Jessica Lovnicki et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
MicroRNA determinants of neuroendocrine differentiation in metastatic castration-resistant prostate cancer
Divya Bhagirath et al.
ONCOGENE (2020)
The miR-361-3p increases enzalutamide (Enz) sensitivity via targeting the ARv7 and MKNK2 to better suppress the Enz-resistant prostate cancer
Bianjiang Liu et al.
CELL DEATH & DISEASE (2020)
Cancer-associated fibroblast-secreted exosomal miR-423-5p promotes chemotherapy resistance in prostate cancer by targeting GREM2 through the TGF-β signaling pathway
Guang Shan et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
Large-scale Circulating microRNA Profiling for the Liquid Biopsy of Prostate Cancer
Fumihiko Urabe et al.
CLINICAL CANCER RESEARCH (2019)
Exosome-derived miR-27a produced by PSC-27 cells contributes to prostate cancer chemoresistance through p53
Zhigang Cao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Proteogenomic Characterization of Patient-Derived Xenografts Highlights the Role of REST in Neuroendocrine Differentiation of Castration-Resistant Prostate Cancer
Amilcar Flores-Morales et al.
CLINICAL CANCER RESEARCH (2019)
Targeting Wnt/EZH2/microRNA-708 signaling pathway inhibits neuroendocrine differentiation in prostate cancer
Jingxuan Shan et al.
CELL DEATH DISCOVERY (2019)
A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers
Himisha Beltran et al.
CLINICAL CANCER RESEARCH (2019)
Circulating microRNAs and treatment response in the Phase II SWOG S0925 study for patients with new metastatic hormone-sensitive prostate cancer
Heather H. Cheng et al.
PROSTATE (2018)
MicroRNA-195 regulates docetaxel resistance by targeting clusterin in prostate cancer
Xiaokun Ma et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
microRNA-323 upregulation promotes prostate cancer growth and docetaxel resistance by repressing p73
Qiruo Gao et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Trends in Incidence and 5-Year Mortality in Men With Newly Diagnosed, Metastatic Prostate Cancer-A Population-Based Analysis of 2 National Cohorts
John T. Helgstrand et al.
CANCER (2018)
The potential of AR-V7 as a therapeutic target
Takuma Uo et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2018)
Epidemiology of prostate cancer in Asian countries
Takahiro Kimura et al.
INTERNATIONAL JOURNAL OF UROLOGY (2018)
Extracellular vesicles: Toward a clinical application in urological cancer treatment
Fumihiko Urabe et al.
INTERNATIONAL JOURNAL OF UROLOGY (2018)
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial
Christos E. Kyriakopoulos et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in the bone metastatic microenvironment via targeting ARHGAP1 and FAM134A
Kyoko Hashimoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
MicroRNA-652 induces NED in LNCaP and EMT in PC3 prostate cancer cells
Robert K. Nam et al.
Oncotarget (2018)
MicroRNA-23b and microRNA-27b plus flutamide treatment enhances apoptosis rate and decreases CCNG1 expression in a castration-resistant prostate cancer cell line
Ruan CA Pimenta et al.
TUMOR BIOLOGY (2018)
The Master Neural Transcription Factor BRN2 Is an Androgen Receptor-Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer
Jennifer L. Bishop et al.
CANCER DISCOVERY (2017)
Silencing of miR-193a-5p increases the chemosensitivity of prostate cancer cells to docetaxel
Zhan Yang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study
Nico van Zandwijk et al.
LANCET ONCOLOGY (2017)
FOXA1 inhibits prostate cancer neuroendocrine differentiation
J. Kim et al.
ONCOGENE (2017)
MicroRNA-181a promotes docetaxel resistance in prostate cancer cells
Cameron M. Armstrong et al.
PROSTATE (2017)
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53-and RB1-deficient prostate cancer
Ping Mu et al.
SCIENCE (2017)
Phase 2 study of circulating microRNA biomarkers in castration-resistant prostate cancer
Hui-Ming Lin et al.
BRITISH JOURNAL OF CANCER (2017)
Dysregulation of miR-212 Promotes Castration Resistance through hnRNPH1-Mediated Regulation of AR and AR-V7: Implications for Racial Disparity of Prostate Cancer
Yijun Yang et al.
CLINICAL CANCER RESEARCH (2016)
miR-138-Mediated Regulation of KINDLIN-2 Expression Modulates Sensitivity to Chemotherapeutics
Khalid Sossey-Alaoui et al.
MOLECULAR CANCER RESEARCH (2016)
N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer
Etienne Dardenne et al.
CANCER CELL (2016)
miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1
Yuan Wang et al.
MOLECULAR CANCER (2016)
Targeting EZH2 in cancer
Kimberly H. Kim et al.
NATURE MEDICINE (2016)
miRNA Deregulation in Cancer Cells and the Tumor Microenvironment
Rajesha Rupaimoole et al.
CANCER DISCOVERY (2016)
Platinum and PARP Inhibitor Resistance Due to Overexpression of MicroRNA-622 in BRCA1-Mutant Ovarian Cancer
Young Eun Choi et al.
CELL REPORTS (2016)
MiR-323 Inhibits Prostate Cancer Vascularization Through Adiponectin Receptor
Qiruo Gao et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Urinary miR-183 and miR-205 do not surpass PCA3 in urine as predictive markers for prostate biopsy outcome despite their highly dysregulated expression in prostate cancer tissue
Carsten Stephan et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2015)
Exosomal miR-1290 and miR-375 as Prognostic Markers in Castration-resistant Prostate Cancer
Xiaoyi Huang et al.
EUROPEAN UROLOGY (2015)
Functional significance of aberrantly expressed microRNAs in prostate cancer
Yusuke Goto et al.
INTERNATIONAL JOURNAL OF UROLOGY (2015)
Aberrant regulation of the LIN28A/LIN28B and let-7 loop in human malignant tumors and its effects on the hallmarks of cancer
Tianzhen Wang et al.
MOLECULAR CANCER (2015)
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
Christopher J. Sweeney et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer
Shusuke Akamatsu et al.
CELL REPORTS (2015)
p53 Mutation Directs AURKA Overexpression via miR-25 and FBXW7 in Prostatic Small Cell Neuroendocrine Carcinoma
Zhen Li et al.
MOLECULAR CANCER RESEARCH (2015)
MicroRNA biogenesis pathways in cancer
Shuibin Lin et al.
NATURE REVIEWS CANCER (2015)
Down-regulation of RE-1 silencing transcription factor (REST) in advanced prostate cancer by hypoxia-induced miR-106b∼25
Hongzi Liang et al.
EXPERIMENTAL CELL RESEARCH (2014)
Elevated levels of FOXA1 facilitate androgen receptor chromatin binding resulting in a CRPC-like phenotype
J. L. L. Robinson et al.
ONCOGENE (2014)
miR-200b suppresses cell proliferation, migration and enhances chemosensitivity in prostate cancer by regulating Bmi-1
Junjie Yu et al.
ONCOLOGY REPORTS (2014)
Potential Urinary miRNA Biomarker Candidates for the Accurate Detection of Prostate Cancer among Benign Prostatic Hyperplasia Patients
Taha A. Haj-Ahmad et al.
JOURNAL OF CANCER (2014)
Control of metastatic progression by microRNA regulatory networks
Nora Pencheva et al.
NATURE CELL BIOLOGY (2013)
MicroRNA Profiling in Prostate Cancer - The Diagnostic Potential of Urinary miR-205 and miR-214
Anvesha Srivastava et al.
PLOS ONE (2013)
Changes in circulating microRNA levels associated with prostate cancer
R. J. Bryant et al.
BRITISH JOURNAL OF CANCER (2012)
From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer
Anna V. Lapuk et al.
JOURNAL OF PATHOLOGY (2012)
Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer
S. E. Jalava et al.
ONCOGENE (2012)
Coordinated Regulation of Polycomb Group Complexes through microRNAs in Cancer
Qi Cao et al.
CANCER CELL (2011)
MicroRNA-616 Induces Androgen-Independent Growth of Prostate Cancer Cells by Suppressing Expression of Tissue Factor Pathway Inhibitor TFPI-2
Stephanie Ma et al.
CANCER RESEARCH (2011)
Circulating miRNAs are correlated with tumor progression in prostate cancer
Jan C. Brase et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS
Bin Xu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)
miR-182-Mediated Downregulation of BRCA1 Impacts DNA Repair and Sensitivity to PARP Inhibitors
Patryk Moskwa et al.
MOLECULAR CELL (2011)
Nonhomologous end joining drives poly(ADP-ribose) polymerase (PARP) inhibitor lethality in homologous recombination-deficient cells
Anand G. Patel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets
Himisha Beltran et al.
CANCER DISCOVERY (2011)
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
Johann Sebastian de Bono et al.
LANCET (2010)
Systemic Delivery of Synthetic MicroRNA-16 Inhibits the Growth of Metastatic Prostate Tumors via Downregulation of Multiple Cell-cycle Genes
Fumitaka Takeshita et al.
MOLECULAR THERAPY (2010)
The Role of microRNA-221 and microRNA-222 in Androgen-Independent Prostate Cancer Cell Lines
Tong Sun et al.
CANCER RESEARCH (2009)
The transcriptional foundation of pluripotency
Ian Chambers et al.
DEVELOPMENT (2009)
MicroRNA-143 as a Tumor Suppressor for Bladder Cancer
Tianxin Lin et al.
JOURNAL OF UROLOGY (2009)
MicroRNA expression profiling in prostate cancer
Kati P. Porkka et al.
CANCER RESEARCH (2007)
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
GA Calin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer
IF Tannock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
The polycomb group protein EZH2 is involved in progression of prostate cancer
S Varambally et al.
NATURE (2002)
分享论文
